These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 25092686)

  • 21. Short-term continuous subcutaneous insulin infusion decreases the plasma vaspin levels in patients with type 2 diabetes mellitus concomitant with improvement in insulin sensitivity.
    Li K; Li L; Yang M; Liu H; Liu D; Yang H; Boden G; Yang G
    Eur J Endocrinol; 2011 Jun; 164(6):905-10. PubMed ID: 21471167
    [TBL] [Abstract][Full Text] [Related]  

  • 22. α- or β-Adrenergic blockade does not affect transplanted islet cell responses to hypoglycemia in type 1 diabetes.
    Rickels MR; Bellin MD; Stefanovski D; Peleckis AJ; Dalton-Bakes C; Markmann E; Nguyen HL; Townsend RR; Hering BJ; Naji A
    Am J Physiol Endocrinol Metab; 2024 Jul; ():. PubMed ID: 38984949
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The relation between fasting plasma glucose concentrations and insulin resistance].
    Li L; Wang GX; Li P; Shang XJ; Liu C; Wang YJ; Yue GY
    Zhonghua Nei Ke Za Zhi; 2005 Oct; 44(10):755-8. PubMed ID: 16255885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin infusion during normoglycemia modulates insulin secretion according to whole-body insulin sensitivity.
    Anderwald C; Tura A; Grassi A; Krebs M; Szendroedi J; Roden M; Bischof MG; Luger A; Pacini G
    Diabetes Care; 2011 Feb; 34(2):437-41. PubMed ID: 21216852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute effects of ghrelin administration on glucose and lipid metabolism.
    Vestergaard ET; Djurhuus CB; Gjedsted J; Nielsen S; Møller N; Holst JJ; Jørgensen JO; Schmitz O
    J Clin Endocrinol Metab; 2008 Feb; 93(2):438-44. PubMed ID: 18042651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The potential role of the osteopontin-osteocalcin-osteoprotegerin triad in the pathogenesis of prediabetes in humans.
    Daniele G; Winnier D; Mari A; Bruder J; Fourcaudot M; Pengou Z; Hansis-Diarte A; Jenkinson C; Tripathy D; Folli F
    Acta Diabetol; 2018 Feb; 55(2):139-148. PubMed ID: 29151224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of β-adrenergic receptors in the ventromedial hypothalamus influences counterregulatory responses to hypoglycemia.
    Szepietowska B; Zhu W; Chan O; Horblitt A; Dziura J; Sherwin RS
    Diabetes; 2011 Dec; 60(12):3154-8. PubMed ID: 22013013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparing hormonal and symptomatic responses to experimental hypoglycaemia in insulin- and sulphonylurea-treated Type 2 diabetes.
    Choudhary P; Lonnen K; Emery CJ; MacDonald IA; MacLeod KM; Amiel SA; Heller SR
    Diabet Med; 2009 Jul; 26(7):665-72. PubMed ID: 19573114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beta-adrenergic blockade attenuates insulin resistance induced by tumor necrosis factor.
    Lang CH
    Am J Physiol; 1993 May; 264(5 Pt 2):R984-91. PubMed ID: 8098917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lactate overrides central nervous but not beta-cell glucose sensing in humans.
    Schmid SM; Jauch-Chara K; Hallschmid M; Oltmanns KM; Peters A; Born J; Schultes B
    Metabolism; 2008 Dec; 57(12):1733-9. PubMed ID: 19013298
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction of exercise, insulin, and hypoglycemia studied using euglycemic and hypoglycemic insulin clamps.
    Zinker BA; Allison RG; Lacy DB; Wasserman DH
    Am J Physiol; 1997 Apr; 272(4 Pt 1):E530-42. PubMed ID: 9142871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vanadyl sulfate improves hepatic and muscle insulin sensitivity in type 2 diabetes.
    Cusi K; Cukier S; DeFronzo RA; Torres M; Puchulu FM; Redondo JC
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1410-7. PubMed ID: 11238540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of C-Peptide Status on the Response of Glucagon and Endogenous Glucose Production to Induced Hypoglycemia in T1DM.
    Zenz S; Mader JK; Regittnig W; Brunner M; Korsatko S; Boulgaropoulos B; Magnes C; Raml R; Narath SH; Eller P; Augustin T; Pieber TR
    J Clin Endocrinol Metab; 2018 Apr; 103(4):1408-1417. PubMed ID: 29408994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postprandial serum C-peptide to plasma glucose concentration ratio correlates with oral glucose tolerance test- and glucose clamp-based disposition indexes.
    Okuno Y; Komada H; Sakaguchi K; Nakamura T; Hashimoto N; Hirota Y; Ogawa W; Seino S
    Metabolism; 2013 Oct; 62(10):1470-6. PubMed ID: 23831440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin effect on leucine kinetics in type 2 diabetes mellitus.
    Halvatsiotis PG; Turk D; Alzaid A; Dinneen S; Rizza RA; Nair KS
    Diabetes Nutr Metab; 2002 Jun; 15(3):136-42. PubMed ID: 12173727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of IGF-I on FFA and glucose metabolism in control and type 2 diabetic subjects.
    Pratipanawatr T; Pratipanawatr W; Rosen C; Berria R; Bajaj M; Cusi K; Mandarino L; Kashyap S; Belfort R; DeFronzo RA
    Am J Physiol Endocrinol Metab; 2002 Jun; 282(6):E1360-8. PubMed ID: 12006367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of intramyocellular lipids during hypoglycemia in patients with intensively treated type 1 diabetes.
    Bernroider E; Brehm A; Krssak M; Anderwald C; Trajanoski Z; Cline G; Shulman GI; Roden M
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5559-65. PubMed ID: 15998784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of the 11 beta-hydroxysteroid dehydrogenase inhibitor carbenoxolone on insulin sensitivity in men with type 2 diabetes.
    Andrews RC; Rooyackers O; Walker BR
    J Clin Endocrinol Metab; 2003 Jan; 88(1):285-91. PubMed ID: 12519867
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Higher Endogenous Glucose Production During OGTT vs Isoglycemic Intravenous Glucose Infusion.
    Lund A; Bagger JI; Christensen M; Grøndahl M; van Hall G; Holst JJ; Vilsbøll T; Knop FK
    J Clin Endocrinol Metab; 2016 Nov; 101(11):4377-4384. PubMed ID: 27533305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of the pharmacodynamic profiles of insulin detemir and insulin glargine: a single dose clamp study in people with type 2 diabetes.
    Luzio SD; Dunseath GJ; Atkinson MD; Owens DR
    Diabetes Metab; 2013 Dec; 39(6):537-42. PubMed ID: 24139704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.